News

CEMMA and LipoCoat Announce Partnership for Coated CVC Catheter

Central Venous Catheter Co-Development
Jasper van Weerd
Bram Pape
April 20, 2022
CEMMA Medical and LipoCoat partnership for a coated central venous catheter

Introduction

CEMMA Medical and LipoCoat BV announce a co-development partnership for central venous catheters. CEMMA & LipoCoat CVC CollaborationTaipei / Enschede, April 20, 2022 — CEMMA Medical and LipoCoat co-developed a coated Central Venous Catheter (CVC) prototype demonstrating a 2-log reduction in bacterial attachment without antibiotics.
CEMMA & LipoCoat CVC CollaborationTaipei / Enschede, April 20, 2022 — CEMMA Medical and LipoCoat co-developed a coated Central Venous Catheter (CVC) prototype demonstrating a 2-log reduction in bacterial attachment without antibiotics.

References

Pre-clinical CVC bacterial attachment study data

Explore Partnership Opportunities

Connect with our business development team to discuss OEM partnerships and regulatory strategy.

Updates

Also interesting

Mockup of the LipoCoat technology brochure
Brochures

A coating inspired by the cell membrane: LipoCoat® in three applications

LipoCoat® is a 5 nm phospholipid coating that stops proteins and bacteria from adhering. The new technology brochure shows how it performs on catheters, contact lenses and needles, and how it fits your production line.

Lipocoat team celebrating the company's 10th anniversary
News

Lipocoat Group celebrates its 10th anniversary and breaks ground on a new production lab in Enschede.

Lipocoat Group is building a 500-square-meter production lab across from the University of Twente and is marking its tenth anniversary. Constantijn van Oranje started construction.

Ultrasound-guided needle procedure with a SonoCoat coated needle
Publication

SonoCoat® Technology Featured in Scientific Publications

Four independent peer-reviewed studies have evaluated SonoCoat®, from EUS-FNA needles to prostate brachytherapy. What each one tested, and what it found.